Counsel Health

-72%

est. 2Y upside i

HealthcareSeries A

Counsel Health is an AI-enabled virtual care company that combines medical AI with in-house physicians to deliver immediate, personalized guidance for nearly any medical concern.

Rank

#2000

Sector

Digital Health

Est. Liquidity

~4Y

Data Quality

Data: Medium

Counsel Health presents a moderate upside opportunity for a job seeker, with an estimated expected upside of 49.25% over a two-year horizon.

Last updated: March 10, 2026

Bull (20%)+350%

Counsel Health achieves significant market penetration by securing major enterprise partnerships with multiple large payers and health systems, leveraging its AI-physician model to demonstrate substantial cost savings and improved patient outcomes. This leads to rapid revenue growth, justifying a valuation of approximately $697.5M, a 3.5x increase from its current valuation.

Base (35%)+50%

Counsel Health continues to grow steadily, expanding its physician network and member base, particularly within its freemium and direct-to-consumer offerings, while securing a few moderate enterprise deals. It maintains its niche against traditional telehealth, reaching a valuation of around $232.5M, a 50% increase, but faces ongoing competitive pressure and regulatory challenges.

Bear (45%)-85%

Dominant incumbents like Amwell and MD Live, or even large healthcare systems, successfully integrate similar AI-physician models or acquire smaller competitors, commoditizing Counsel Health's offering. Regulatory hurdles or slower-than-expected adoption of AI in healthcare limit growth, leading to a down round or acquisition at a significantly reduced valuation of $23.25M, wiping out most common stock value due to liquidation preferences.

Est. time to liquidity~3.5 years

Preference Stack Risk

high

Funding Intensity

23%

Investors hold $36M in liquidation preferences. In an exit at or below $36M, common shareholders would receive nothing. In a $155M exit, common shareholders would see $119M distributed.

Dilution Risk

high

As a Series A company, Counsel Health will likely undergo multiple additional funding rounds (Series B, C, etc.), which will dilute existing common stock holdings.

Secondary Liquidity

none

There is no indication of an active secondary market or tender offers for Counsel Health's shares at this early stage.

Questions to Ask at the Interview

Strategic questions based on Counsel Health's data — designed to show you've done your homework.

1
“Given the competitive landscape with established players like Amwell and MD Live, how does Counsel Health plan to sustain its competitive moat and differentiate its AI-physician model over the next 2-3 years?”
2
“With over 100,000 members served and a hybrid freemium/enterprise model, what are the key metrics (e.g., ARR, customer acquisition cost, LTV) the company is tracking to demonstrate scalable growth and unit economics to investors?”
3
“As a Series A company with a significant preference stack, how does Counsel Health envision its path to a liquidity event (e.g., IPO or acquisition) within the next 3-5 years, and what are the milestones for employee equity value creation?”

Community

Valuation Sentiment

Our model estimates -72% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.